Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice.
about
Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: A systematic review and meta-analysis.The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.Mouse models of gallstone disease.Recent advances in understanding and managing cholesterol gallstones
P2860
Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Estrogen induces two distinct ...... ERα and GPR30 in female mice.
@ast
Estrogen induces two distinct ...... ERα and GPR30 in female mice.
@en
type
label
Estrogen induces two distinct ...... ERα and GPR30 in female mice.
@ast
Estrogen induces two distinct ...... ERα and GPR30 in female mice.
@en
prefLabel
Estrogen induces two distinct ...... ERα and GPR30 in female mice.
@ast
Estrogen induces two distinct ...... ERα and GPR30 in female mice.
@en
P2093
P2860
P356
P1476
Estrogen induces two distinct ...... g ERα and GPR30 in female mice
@en
P2093
David Q-H Wang
Tony Y Wang
P2860
P304
P356
10.1194/JLR.M059121
P577
2015-07-07T00:00:00Z